{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:34:39Z","timestamp":1794346479009,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Internal fund from Houston Methodist Research Institute (to W.C.).","id":[{"id":"https:\/\/ror.org\/01mcrxx35","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41590-025-02176-w","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:02:25Z","timestamp":1750050145000},"page":"1062-1073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-7243","authenticated-orcid":false,"given":"Xiaolong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-0606","authenticated-orcid":false,"given":"Zheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8880-2520","authenticated-orcid":false,"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-6118","authenticated-orcid":false,"given":"Xiao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-0280","authenticated-orcid":false,"given":"Dawei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie J.","family":"Minze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-3739","authenticated-orcid":false,"given":"Wenhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2176_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","volume":"32","author":"A Lopez-Soto","year":"2017","unstructured":"Lopez-Soto, A., Gonzalez, S., Smyth, M. J. & Galluzzi, L. Control of metastasis by NK cells. Cancer Cell 32, 135\u2013154 (2017).","journal-title":"Cancer Cell"},{"key":"2176_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. NK cell-based cancer immunotherapy: from basic biology to clinical development. J. Hematol. Oncol. 14, 7 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2176_CR3","volume":"19","author":"SY Wu","year":"2020","unstructured":"Wu, S. Y., Fu, T., Jiang, Y. Z. & Shao, Z. M. Natural killer cells in cancer biology and therapy. Mol. Cancer 19, 120 (2020).","journal-title":"Mol. Cancer"},{"key":"2176_CR4","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1158\/0008-5472.CAN-08-3807","volume":"69","author":"C Menard","year":"2009","unstructured":"Menard, C. et al. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Cancer Res. 69, 3563\u20133569 (2009).","journal-title":"Cancer Res."},{"key":"2176_CR5","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.162.11.6658","volume":"162","author":"MJ Smyth","year":"1999","unstructured":"Smyth, M. J. et al. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162, 6658\u20136662 (1999).","journal-title":"J. Immunol."},{"key":"2176_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","volume":"97","author":"SE Street","year":"2001","unstructured":"Street, S. E., Cretney, E. & Smyth, M. J. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97, 192\u2013197 (2001).","journal-title":"Blood"},{"key":"2176_CR7","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.4049\/jimmunol.138.12.4539","volume":"138","author":"WE Seaman","year":"1987","unstructured":"Seaman, W. E., Sleisenger, M., Eriksson, E. & Koo, G. C. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138, 4539\u20134544 (1987).","journal-title":"J. Immunol."},{"key":"2176_CR8","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","volume":"36","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers. Oncogene 36, 6143\u20136153 (2017).","journal-title":"Oncogene"},{"key":"2176_CR9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723\u2013732 (2018).","journal-title":"Nat. Immunol."},{"key":"2176_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcimb.2020.00049","volume":"10","author":"SJ Judge","year":"2020","unstructured":"Judge, S. J., Murphy, W. J. & Canter, R. J. Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, anergy, and senescence. Front. Cell Infect. Microbiol. 10, 49 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2176_CR11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","volume":"8","author":"J Bi","year":"2017","unstructured":"Bi, J. & Tian, Z. NK cell exhaustion. Front. Immunol. 8, 760 (2017).","journal-title":"Front. Immunol."},{"key":"2176_CR12","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI74337","volume":"124","author":"M Ardolino","year":"2014","unstructured":"Ardolino, M. et al. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J. Clin. Invest. 124, 4781\u20134794 (2014).","journal-title":"J. Clin. Invest."},{"key":"2176_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","volume":"2","author":"IP da Silva","year":"2014","unstructured":"da Silva, I. P. et al. Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunol. Res 2, 410\u2013422 (2014).","journal-title":"Cancer Immunol. Res"},{"key":"2176_CR14","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3892\/or.2015.4149","volume":"34","author":"H Komita","year":"2015","unstructured":"Komita, H. et al. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3\/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors. Oncol. Rep. 34, 2099\u20132105 (2015).","journal-title":"Oncol. Rep."},{"key":"2176_CR15","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","volume":"116","author":"DM Benson Jr.","year":"2010","unstructured":"Benson, D. M. Jr. et al. The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood 116, 2286\u20132294 (2010).","journal-title":"Blood"},{"key":"2176_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)80453-5","volume":"91","author":"M Kondo","year":"1997","unstructured":"Kondo, M., Weissman, I. L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661\u2013672 (1997).","journal-title":"Cell"},{"key":"2176_CR17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","volume":"9","author":"AM Abel","year":"2018","unstructured":"Abel, A. M., Yang, C., Thakar, M. S. & Malarkannan, S. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 9, 1869 (2018).","journal-title":"Front Immunol."},{"key":"2176_CR18","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","volume":"113","author":"L Chiossone","year":"2009","unstructured":"Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488\u20135496 (2009).","journal-title":"Blood"},{"key":"2176_CR19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","volume":"133","author":"B Fu","year":"2011","unstructured":"Fu, B. et al. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 133, 350\u2013359 (2011).","journal-title":"Immunology"},{"key":"2176_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535\u2013584 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"2176_CR21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.187.6.967","volume":"187","author":"T Ohteki","year":"1998","unstructured":"Ohteki, T. et al. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha\/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187, 967\u2013972 (1998).","journal-title":"J. Exp. Med."},{"key":"2176_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.192.3.325","volume":"192","author":"M Lohoff","year":"2000","unstructured":"Lohoff, M. et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 192, 325\u2013336 (2000).","journal-title":"J. Exp. Med."},{"key":"2176_CR23","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.4049\/jimmunol.174.10.6005","volume":"174","author":"S Taki","year":"2005","unstructured":"Taki, S., Nakajima, S., Ichikawa, E., Saito, T. & Hida, S. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 174, 6005\u20136012 (2005).","journal-title":"J. Immunol."},{"key":"2176_CR24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.immuni.2018.04.018","volume":"48","author":"NM Adams","year":"2018","unstructured":"Adams, N. M. et al. Transcription factor IRF8 orchestrates the adaptive natural killer cell response. Immunity 48, 1172\u20131182.e1176 (2018).","journal-title":"Immunity"},{"key":"2176_CR25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41590-023-01620-z","volume":"24","author":"EK Santosa","year":"2023","unstructured":"Santosa, E. K. et al. Control of nutrient uptake by IRF4 orchestrates innate immune memory. Nat. Immunol. 24, 1685\u20131697 (2023).","journal-title":"Nat. Immunol."},{"key":"2176_CR26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.celrep.2018.07.060","volume":"24","author":"CD Geary","year":"2018","unstructured":"Geary, C. D. et al. Non-redundant ISGF3 components promote NK cell survival in an auto-regulatory manner during viral infection. Cell Rep. 24, 1949\u20131957.e1946 (2018).","journal-title":"Cell Rep."},{"key":"2176_CR27","volume":"26","author":"H Yan","year":"2023","unstructured":"Yan, H. et al. The transcription factor IRF4 determines the anti-tumor immunity of CD8+ T cells. iScience 26, 108087 (2023).","journal-title":"iScience"},{"key":"2176_CR28","first-page":"0271","volume":"6","author":"A Yu","year":"2023","unstructured":"Yu, A. et al. Continuous expression of interferon regulatory factor 4 sustains CD8+ T cell immunity against tumor. Research (Wash. DC) 6, 0271 (2023).","journal-title":"Research (Wash. DC)"},{"key":"2176_CR29","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.healun.2021.06.008","volume":"40","author":"G Wang","year":"2021","unstructured":"Wang, G. et al. IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection. J. Heart Lung Transpl. 40, 1122\u20131132 (2021).","journal-title":"J. Heart Lung Transpl."},{"key":"2176_CR30","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M","volume":"31","author":"EE Rosmaraki","year":"2001","unstructured":"Rosmaraki, E. E. et al. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31, 1900\u20131909 (2001).","journal-title":"Eur. J. Immunol."},{"key":"2176_CR31","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2011-04-348912","volume":"118","author":"JW Fathman","year":"2011","unstructured":"Fathman, J. W. et al. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118, 5439\u20135447 (2011).","journal-title":"Blood"},{"key":"2176_CR32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.275.5299.540","volume":"275","author":"HW Mittrucker","year":"1997","unstructured":"Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF\/IRF4 for mature B and T lymphocyte function. Science 275, 540\u2013543 (1997).","journal-title":"Science"},{"key":"2176_CR33","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.4049\/jimmunol.178.8.4764","volume":"178","author":"ND Huntington","year":"2007","unstructured":"Huntington, N. D. et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178, 4764\u20134770 (2007).","journal-title":"J. Immunol."},{"key":"2176_CR34","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.1300876","volume":"192","author":"M Malaise","year":"2014","unstructured":"Malaise, M. et al. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma. J. Immunol. 192, 1954\u20131961 (2014).","journal-title":"J. Immunol."},{"key":"2176_CR35","doi-asserted-by":"crossref","first-page":"e127729","DOI":"10.1172\/jci.insight.127729","volume":"5","author":"M Alvarez","year":"2019","unstructured":"Alvarez, M. et al. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway. JCI Insight 5, e127729 (2019).","journal-title":"JCI Insight"},{"key":"2176_CR36","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1084\/jem.20172018","volume":"215","author":"UU Uche","year":"2018","unstructured":"Uche, U. U. et al. PIK3IP1\/TrIP restricts activation of T cells through inhibition of PI3K\/Akt. J. Exp. Med. 215, 3165\u20133179 (2018).","journal-title":"J. Exp. Med."},{"key":"2176_CR37","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","volume":"128","author":"J Hsu","year":"2018","unstructured":"Hsu, J. et al. Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade. J. Clin. Invest. 128, 4654\u20134668 (2018).","journal-title":"J. Clin. Invest."},{"key":"2176_CR38","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-20-0575","volume":"26","author":"JM Chauvin","year":"2020","unstructured":"Chauvin, J. M. et al. IL15 Stimulation with TIGIT blockade reverses CD155-mediated NK-cell dysfunction in melanoma. Clin. Cancer Res. 26, 5520\u20135533 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2176_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.04.001","volume":"81","author":"Y He","year":"2017","unstructured":"He, Y. et al. Contribution of inhibitory receptor TIGIT to NK cell education. J. Autoimmun. 81, 1\u201312 (2017).","journal-title":"J. Autoimmun."},{"key":"2176_CR40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1074-7613(04)00076-7","volume":"20","author":"MJ Townsend","year":"2004","unstructured":"Townsend, M. J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20, 477\u2013494 (2004).","journal-title":"Immunity"},{"key":"2176_CR41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","volume":"36","author":"SM Gordon","year":"2012","unstructured":"Gordon, S. M. et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55\u201367 (2012).","journal-title":"Immunity"},{"key":"2176_CR42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727\u2013729 (1999).","journal-title":"Science"},{"key":"2176_CR43","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2010-07-297101","volume":"117","author":"G Sciume","year":"2011","unstructured":"Sciume, G. et al. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 117, 4467\u20134475 (2011).","journal-title":"Blood"},{"key":"2176_CR44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2019.03.012","volume":"71","author":"RS Wijaya","year":"2019","unstructured":"Wijaya, R. S. et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J. Hepatol. 71, 252\u2013264 (2019).","journal-title":"J. Hepatol."},{"key":"2176_CR45","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1158\/1078-0432.CCR-18-4134","volume":"25","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Pik3ip1 is a negative immune regulator that inhibits antitumor T-cell immunity. Clin. Cancer Res. 25, 6180\u20136194 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2176_CR46","doi-asserted-by":"crossref","first-page":"18324","DOI":"10.1073\/pnas.1112064108","volume":"108","author":"E Narni-Mancinelli","year":"2011","unstructured":"Narni-Mancinelli, E. et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl Acad. Sci. USA 108, 18324\u201318329 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2176_CR47","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.immuni.2017.11.003","volume":"47","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Ablation of transcription factor IRF4 promotes transplant acceptance by driving allogenic CD4+ T cell dysfunction. Immunity 47, 1114\u20131128 e1116 (2017).","journal-title":"Immunity"},{"key":"2176_CR48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41423-022-00852-7","volume":"19","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. The RNA helicase DHX15 is a critical regulator of natural killer-cell homeostasis and functions. Cell Mol. Immunol. 19, 687\u2013701 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"2176_CR49","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/ajt.15870","volume":"20","author":"D Zou","year":"2020","unstructured":"Zou, D. et al. T cell exhaustion is associated with antigen abundance and promotes transplant acceptance. Am. J. Transpl. 20, 2540\u20132550 (2020).","journal-title":"Am. J. Transpl."},{"key":"2176_CR50","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 e1821 (2019).","journal-title":"Cell"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02176-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:48:06Z","timestamp":1751291286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02176-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02176-w","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}